INFI Annual Current Liabilities
$13.63 M
+$328.00 K+2.47%
31 December 2022
Summary:
As of January 21, 2025, INFI annual total current liabilities is $13.63 million, with the most recent change of +$328.00 thousand (+2.47%) on December 31, 2022. During the last 3 years, it has risen by +$3.93 million (+40.52%).INFI Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Quarterly Current Liabilities
$12.06 M
+$775.00 K+6.87%
30 June 2023
Summary:
As of January 21, 2025, INFI quarterly total current liabilities is $12.06 million, with the most recent change of +$775.00 thousand (+6.87%) on June 30, 2023. Over the past year, it has dropped by -$2.27 million (-15.87%).INFI Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.5% | -15.9% |
| 3 y3 years | +40.5% | +35.9% |
| 5 y5 years | +17.5% | +112.4% |
INFI Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -80.5% | -83.8% |
Infinity Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $12.06 M(+6.9%) |
| Mar 2023 | - | $11.29 M(-17.2%) |
| Dec 2022 | $13.63 M(+2.5%) | $13.63 M(-4.0%) |
| Sept 2022 | - | $14.20 M(-1.0%) |
| June 2022 | - | $14.34 M(+7.1%) |
| Mar 2022 | - | $13.39 M(+0.7%) |
| Dec 2021 | $13.30 M(+20.4%) | $13.30 M(+7.7%) |
| Sept 2021 | - | $12.35 M(+17.0%) |
| June 2021 | - | $10.55 M(+11.6%) |
| Mar 2021 | - | $9.46 M(-14.4%) |
| Dec 2020 | $11.05 M(+13.9%) | $11.05 M(+12.3%) |
| Sept 2020 | - | $9.83 M(+10.8%) |
| June 2020 | - | $8.88 M(+4.9%) |
| Mar 2020 | - | $8.46 M(-12.7%) |
| Dec 2019 | $9.70 M(+25.7%) | $9.70 M(+10.8%) |
| Sept 2019 | - | $8.75 M(+6.8%) |
| June 2019 | - | $8.19 M(+9.8%) |
| Mar 2019 | - | $7.46 M(-3.4%) |
| Dec 2018 | $7.72 M(-33.4%) | $7.72 M(+26.4%) |
| Sept 2018 | - | $6.11 M(+7.5%) |
| June 2018 | - | $5.68 M(+25.0%) |
| Mar 2018 | - | $4.54 M(-60.8%) |
| Dec 2017 | $11.60 M(-51.4%) | $11.60 M(+6.7%) |
| Sept 2017 | - | $10.87 M(-0.6%) |
| June 2017 | - | $10.94 M(+3.4%) |
| Mar 2017 | - | $10.58 M(-55.7%) |
| Dec 2016 | $23.86 M(-65.9%) | $23.86 M(-7.9%) |
| Sept 2016 | - | $25.90 M(-41.5%) |
| June 2016 | - | $44.27 M(-33.7%) |
| Mar 2016 | - | $66.77 M(-4.7%) |
| Dec 2015 | $70.06 M(+27.7%) | $70.06 M(-5.7%) |
| Sept 2015 | - | $74.31 M(+27.6%) |
| June 2015 | - | $58.23 M(+31.4%) |
| Mar 2015 | - | $44.32 M(-19.2%) |
| Dec 2014 | $54.88 M(+147.1%) | $54.88 M(-6.1%) |
| Sept 2014 | - | $58.41 M(+120.4%) |
| June 2014 | - | $26.51 M(+1.5%) |
| Mar 2014 | - | $26.12 M(+17.6%) |
| Dec 2013 | $22.21 M(+19.0%) | $22.21 M(-5.7%) |
| Sept 2013 | - | $23.54 M(+12.9%) |
| June 2013 | - | $20.85 M(+20.6%) |
| Mar 2013 | - | $17.29 M(-7.4%) |
| Dec 2012 | $18.66 M(-35.6%) | $18.66 M(+4.5%) |
| Sept 2012 | - | $17.86 M(-51.8%) |
| June 2012 | - | $37.09 M(+31.4%) |
| Mar 2012 | - | $28.23 M(-2.6%) |
| Dec 2011 | $28.99 M | $28.99 M(+14.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $25.44 M(+20.2%) |
| June 2011 | - | $21.15 M(+9.2%) |
| Mar 2011 | - | $19.38 M(-30.2%) |
| Dec 2010 | $27.75 M(+95.4%) | $27.75 M(-3.8%) |
| Sept 2010 | - | $28.86 M(+93.1%) |
| June 2010 | - | $14.95 M(-2.9%) |
| Mar 2010 | - | $15.40 M(+8.4%) |
| Dec 2009 | $14.20 M(-11.4%) | $14.20 M(-8.8%) |
| Sept 2009 | - | $15.58 M(-7.6%) |
| June 2009 | - | $16.86 M(+3.8%) |
| Mar 2009 | - | $16.25 M(+1.3%) |
| Dec 2008 | $16.03 M(-35.2%) | $16.03 M(-19.1%) |
| Sept 2008 | - | $19.81 M(-3.3%) |
| June 2008 | - | $20.48 M(+7.9%) |
| Mar 2008 | - | $18.97 M(-23.3%) |
| Dec 2007 | $24.74 M(-0.4%) | $24.74 M(+17.6%) |
| Sept 2007 | - | $21.03 M(-0.1%) |
| June 2007 | - | $21.04 M(+2.6%) |
| Mar 2007 | - | $20.50 M(-17.4%) |
| Dec 2006 | $24.83 M(+111.2%) | $24.83 M(-11.8%) |
| Sept 2006 | - | $28.16 M(+451.7%) |
| June 2006 | - | $5.10 M(-9.4%) |
| Mar 2006 | - | $5.63 M(-52.1%) |
| Dec 2005 | $11.76 M(+66.1%) | $11.76 M(+80.8%) |
| Sept 2005 | - | $6.51 M(-10.4%) |
| June 2005 | - | $7.26 M(+5.0%) |
| Mar 2005 | - | $6.91 M(-2.3%) |
| Dec 2004 | $7.08 M(-34.7%) | $7.08 M(+4.9%) |
| Sept 2004 | - | $6.75 M(-21.7%) |
| June 2004 | - | $8.62 M(+14.4%) |
| Mar 2004 | - | $7.54 M(-30.4%) |
| Dec 2003 | $10.84 M(+44.5%) | $10.84 M(+37.4%) |
| Sept 2003 | - | $7.89 M(-7.1%) |
| June 2003 | - | $8.49 M(+18.2%) |
| Mar 2003 | - | $7.18 M(-4.2%) |
| Dec 2002 | $7.50 M(-11.1%) | $7.50 M(-19.8%) |
| Sept 2002 | - | $9.35 M(+3.7%) |
| June 2002 | - | $9.02 M(+1.2%) |
| Mar 2002 | - | $8.91 M(+5.6%) |
| Dec 2001 | $8.44 M(-16.4%) | $8.44 M(-18.2%) |
| Sept 2001 | - | $10.31 M(+8.6%) |
| June 2001 | - | $9.49 M(+3.2%) |
| Mar 2001 | - | $9.19 M(-8.8%) |
| Dec 2000 | $10.08 M(-8.8%) | $10.08 M(-4.2%) |
| Sept 2000 | - | $10.53 M(-16.6%) |
| June 2000 | - | $12.62 M(+16.4%) |
| Mar 2000 | - | $10.84 M |
| Dec 1999 | $11.05 M | - |
FAQ
- What is Infinity Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals annual current liabilities year-on-year change?
- What is Infinity Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals quarterly current liabilities year-on-year change?
What is Infinity Pharmaceuticals annual total current liabilities?
The current annual current liabilities of INFI is $13.63 M
What is the all time high annual current liabilities for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high annual total current liabilities is $70.06 M
What is Infinity Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, INFI annual total current liabilities has changed by +$328.00 K (+2.47%)
What is Infinity Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of INFI is $12.06 M
What is the all time high quarterly current liabilities for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high quarterly total current liabilities is $74.31 M
What is Infinity Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, INFI quarterly total current liabilities has changed by -$2.27 M (-15.87%)